Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-590-9 | CAS number: 4948-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05-OCT-2005 - 25-JAN-2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- -
- EC Number:
- 479-300-2
- EC Name:
- -
- Molecular formula:
- unspecified
- IUPAC Name:
- Reaction mass of Bisbenzimidazo[2,1-a:1',2'-b']anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-6,11-dione and Bisbenzimidazo[2,1-a:2',1'-a']anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-10,21-dione
- Test material form:
- solid: nanoform, no surface treatment
- Details on test material:
- - State of aggregation: solid, powder
- Particle size distribution (TEM): 30.3 nm (D50)
- Mass median aerodynamic diameter (MMAD): not specified
- Geometric standard deviation (GSD): not specified
- Shape of particles: spherical
- Surface area of particles: 16.8 m²/g
- Crystal structure: crystalline
- Coating: no
- Surface properties: not applicable
- Density: 1515 kg/m³ at 20°C
- Moisture content: refer to IUCLID chapter 1
- Residual solvent: refer to IUCLID chapter 1
- Activation: not applicable
- Stabilisation: not applicable
Constituent 1
- Specific details on test material used for the study:
- - Physical state: Solid, black powder
- Analytical purity: > 99%
- Storage condition of test material: Room temperature
- Expiration date of the lot/batch: 18 November 2020
- CAS No. Cis: 55034-81-6 Trans: 55034-79-2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaHsdRcc(SPF )
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd Laboratory Animal Service, Füllinsdorf / Switzerland
- Age at study initiation: 8- 12 weeks (beginning of acclimatization )
- Weight at study initiation: 16 g - 24 g (ordered )
- Housing: Individual in Makrolon type-2 cages with standard softwood bedding.
- Diet: Pelleted standard Kliba 3433, batch no . 39/05 mouse maintenance diet (Provimi Kliba AG, CH-4303 Kaiseraugst) available ad libitum
- Water: Community tap water from Itingen, available ad libitum.
- Acclimation period: Under test conditions after health examination. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + 3°C
- Humidity (%): 30 - 70 %
- Air changes (per hr): 10 - 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hour fluorescent light / 12 hour dark cycle with at least 8 hours music during the light period.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 5%, 10% and 25% (based a non-GLP local toxicity pre-test, 25% was the highest technically applicable concentration in the chosen vehicle)
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
• In a non-GLP solubility pre-test, the test item was tested in different vehicles: acetone/olive oil (4/1, v/v; A00), ethanol/water (7/3, v/v) and N,N-dimethylformamide (DMF). The pre-test results showed that 25 % in acetone/olive oil (4/1, v/v) was the highest technically applicable concentration. Only lower concentrations suitable for application could be produced with the other vehicles.
• In a non-GLP local toxicity pre-test with the suitable vehicle A00, concentrations were determined in three single animals each treated with one of three different concentrations (5 %, 10 % and 25 %) in both ears on three consecutive days.
After each topical application, the residual test item was found at all dosing sites.
MAIN STUDY
TREATMENT PREPARATION AND ADMINISTRATION:
The test item was placed into a volumetric flask on a tared Mettler balance and the vehicle acetone/olive oil (4/1, v/v) was quantitatively added. The weight/volume (w/v) dilutions were prepared individually using a magnetic stirrer as homogenizer. Test item formulations were made freshly before each dosing occasion and no more than 4 hours prior to application to the ears. Homogeneity of the test item in the vehicle was maintained until start of treatment using an appropriate homogenizer.
Three groups each of five female mice were treated daily with the test item at concentrations of 5%, 10% and 25% in acetone/olive oil (4/1, v/v) by topical application to the dorsum of each ear lobe (left and right) for three consecutive days (application volume: 25 µl). 25% was the highest technically applicable concentration in the vehicle. A control group of five mice was treated with the vehicle acetone/olive oil (4/1, v/v) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a ß-scintillation counter.
- Criteria used to consider a positive response:
A test item is regarded as a sensitizer in the LLNA if the following criteria are fulfilled :
First, exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the STIMULATION INDEX (S .I .).
Second, the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
DETERMINATION OF EAR THICKNESS
On days 1, 2 and 3 (before application) as well as on day 6 (prior to necropsy), the thickness of both ear (left and right) of each animal was measured using a micrometer.
Any other observation (erythema, colouration, presence of residual test item, crust, etc .) was noted at each time point. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations of body weights and dpm values were calculated.
Dunnett-test was conducted for assessment of the difference significance between the test item groups and the negative control (vehicle) group.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- 5%
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- 10%
- Parameter:
- SI
- Value:
- 0.8
- Test group / Remarks:
- 25%
Any other information on results incl. tables
No biological relevant changes in ear thickness occurred. No deaths occurred during the study period. Neither clinical / local signs nor other findings were observed in any animals of the control group. After the first topical application, the residual test item was found at both dosing sites in all mice of the test item groups, persisting for the remainder of the in-life phase of the study. The body weight of the animals, recorded prior to the first application and prior to necropsy, was within the range commonly recorded for animals of the strain and age.
Statistical Analysis* | |||||
Group | Test item concentration | dpm/node M (SD) | S.I.M (SD) | t value | Conclusion |
CG 1 | - | 516 (79) | - | - | - |
TG 2 | 5 % (w/v) | 604 (175) | 1.2 (0.3) | 0.61 | -- |
TG 3 | 10 % (w/v) | 629 (381) | 1.2 (0.7) | 0.78 | -- |
TG 4 | 25 % (w/v) | 404 (169) | 0.8 (0.3) | 0.77 | -- |
S.I. = Stimulation Index
* Dunnett-test (G = 4, N= 20, t= 2.59)
-- no significant difference at p </= 0.05 (two sides)
No dose-response relationship was observed. Calculation of the EC3 value was not performed because no test concentrations produced a Stimulation Index (S.I.) of 3 or higher.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study STIMULATION INDICES of 1 .2, 1 .2 and 0.8 were determined with the test item at concentrations of 5%, 10 % and 25 % in acetone/olive oil (4/1, v/v), respectively. Therefore, the test substance was found to be a non-sensitizer.
- Executive summary:
In order to study a possible contact allergenic potential of the test article, a GLP compliant Local Lymph Node Assay according to the OECD guideline No. 429 was performed. Three groups each of five female mice were treated daily with the test item at concentrations of 5%, 10 % and 25 % in acetone/olive oil (4/1, v/v) by topical application to the dorsum of each ear lobe (left and right) for three consecutive days. 25 % was the highest technically applicable concentration in the vehicle. A control group of five mice was treated with the vehicle acetone/olive oil (4/1, v/v) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a ß-scintillation counter. All treated animals survived the scheduled study period. Neither clinical / local signs nor other findings were observed in any animals of the control group. After the first topical application, the residual test item was found at both dosing sites in all mice of the test item groups (Groups 2-4), persisting for the remainder of the in-life phase of the study. In this study STIMULATION INDICES of 1 .2, 1 .2 and 0.8 were determined with the test item at concentrations of 5%, 10 % and 25 % in acetone/olive oil (4/1, v/v), respectively. Calculation of the EC 3 value was not performed because no test concentrations produced a STIMULATION INDEX (S .I .) of 3 or higher. Based on this result, the test article was found to be a non-sensitizer when tested up to the highest applicable concentration of 25 % in acetone/olive oil (4/1, v/v).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.